Resultats de la cerca - Srilatha Edupuganti
- Mostrar 1 - 20 resultats de 60
- Anar a la pàgina següent
-
1
-
2
Characterization of the Gene Cassette Required for Biosynthesis of the (α1→6)-Linked <i>N</i> -Acetyl- <scp>d</scp> -Mannosamine-1-Phosphate Capsule of Serogroup A <i>Neisseria men... per John S. Swartley, Lijun Liu, Yoon K. Miller, L E Martin, Srilatha Edupuganti, David S. Stephens
Publicat 1998Artigo -
3
-
4
Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination per Rama Akondy, Philip L. Johnson, Helder I. Nakaya, Srilatha Edupuganti, Mark J. Mulligan, Benton Lawson, Joseph D. Miller, Bali Pulendran, Rustom Antia, Rafi Ahmed
Publicat 2015Artigo -
5
Detection of Anti-Yellow Fever Virus Immunoglobulin M Antibodies at 3–4 Years Following Yellow Fever Vaccination per Katherine B. Gibney, Olga I. Kosoy, Marc Fischer, Srilatha Edupuganti, Robert S. Lanciotti, Mark J. Delorey, J. Erin Staples, Amanda J. Panella, Mark J. Mulligan
Publicat 2012Artigo -
6
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus per Lalita Priyamvada, Kendra M. Quicke, William Henry Hudson, Nattawat Onlamoon, Jaturong Sewatanon, Srilatha Edupuganti, Kovit Pattanapanyasat, Kulkanya Chokephaibulkit, Mark J. Mulligan, Patrick C. Wilson, Rafi Ahmed, Mehul S. Suthar, Jens Wrammert
Publicat 2016Artigo -
7
Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant per Robert B. Belshe, Sharon E. Frey, Irene Graham, Mark J. Mulligan, Srilatha Edupuganti, Lisa A. Jackson, Anna Wald, Gregory A. Poland, Robert M. Jacobson, Harry Keyserling, Paul Spearman, Heather Hill, Mark Wolff
Publicat 2011Artigo -
8
2896. Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials per Valeria D. Cantos, Moni B. Neradilek, Kevin Gillespie, Yunda Huang, Allan C. deCamp, Shelly Karuna, Srilatha Edupuganti, Carlos del Rı́o, Valdiléa G. Veloso, Myron S. Cohen, Deborah Donnell, Lawrence Corey, Alison C. Roxby, Colleen F. Kelley
Publicat 2023Artigo -
9
Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood per Mohammed Ata Ur Rasheed, Carole J. Hickman, Marcia McGrew, Sun B. Sowers, Sara Mercader, Amy Hopkins, Vickie Grimes, Tianwei Yu, Jens Wrammert, Mark J. Mulligan, William J. Bellini, Paul A. Rota, Walter A. Orenstein, Rafi Ahmed, Srilatha Edupuganti
Publicat 2019Artigo -
10
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response per Rama Akondy, Nathan D. Monson, Joseph D. Miller, Srilatha Edupuganti, Dirk E. Teuwen, Hong Wu, Farah Quyyumi, Seema Garg, John D. Altman, Carlos del Rı́o, Harry Keyserling, Alexander Ploß, Charles M. Rice, Walter A. Orenstein, Mark J. Mulligan, Rafi Ahmed
Publicat 2009Artigo -
11
Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B<i>gag</i>Vaccines in Healthy Adults per Clayton Harro, Michael Robertson, Michelle Lally, Lori D. O'Neill, Srilatha Edupuganti, Paul Goepfert, Mark J. Mulligan, Frances Priddy, Sheri Dubey, Lisa Kierstead, Xiao Sun, Danilo R. Casimiro, Mark J. DiNubile, John W. Shiver, Randi Y. Leavitt, Devan V. Mehrotra
Publicat 2008Artigo -
12
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells per Guimei Li, Christopher Chiu, Jens Wrammert, Megan McCausland, Sarah F. Andrews, Nai‐Ying Zheng, Jane-Hwei Lee, Min Huang, Xinyan Qu, Srilatha Edupuganti, Mark J. Mulligan, Suman R. Das, Jonathan W. Yewdell, Aneesh K. Mehta, Patrick C. Wilson, Rafi Ahmed
Publicat 2012Artigo -
13
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodefic... per Valeria D. Cantos, Moni B. Neradilek, Yunda Huang, Alison C. Roxby, Kevin Gillespie, Allan C. deCamp, Shelly Karuna, Srilatha Edupuganti, Jorge A Gallardo-Cartagena, Jorge Sánchez, Carlos del Rı́o, Valdiléa G. Veloso, Myron S. Cohen, Deborah Donnell, Lawrence Corey, Colleen F. Kelley
Publicat 2024Artigo -
14
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines per Joseph D. Miller, Robbert van der Most, Rama Akondy, John Glidewell, Sophia Albott, David Masopust, Kaja Murali‐Krishna, Patryce L. Mahar, Srilatha Edupuganti, Susan Lalor, Stéphanie Germon, Carlos del Rı́o, Mark J. Mulligan, Silvija I. Staprans, John D. Altman, Mark B. Feinberg, Rafi Ahmed
Publicat 2008Artigo -
15
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans per Ali H. Ellebedy, Florian Krammer, Guimei Li, Matthew S. Miller, Christopher Chiu, Jens Wrammert, Cathy Chang, Carl W. Davis, Megan McCausland, Rivka Elbein, Srilatha Edupuganti, Paul Spearman, Sarah F. Andrews, Patrick C. Wilson, Adolfo García‐Sastre, Mark J. Mulligan, Aneesh K. Mehta, Peter Palese, Rafi Ahmed
Publicat 2014Artigo -
16
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C) per Christina A. Rostad, Ann Chahroudi, Grace Mantus, Stacey A. Lapp, Mehgan Teherani, Lisa Macoy, Keiko M. Tarquinio, Rajit K. Basu, Carol Kao, W. Matthew Linam, Matthew G. Zimmerman, Pei‐Yong Shi, Vineet D. Menachery, Matthew E. Oster, Srilatha Edupuganti, Evan J. Anderson, Mehul S. Suthar, Jens Wrammert, Preeti Jaggi
Publicat 2020Artigo -
17
EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Braz... per Matthew H. Collins, Gail E. Potter, Matt D. T. Hitchings, Ellie Butler, Michelle Wiles, Jessie K. Kennedy, Sofia B. Pinto, Adla Betsaida Martins Teixeira, Arnau Casanovas‐Massana, Nadine Rouphael, Gregory A. Deye, Cameron P. Simmons, Luciano Andrade Moreira, Maurício Lacerda Nogueira, Derek A. T. Cummings, Albert I. Ko, Mauro Martins Teixeira, Srilatha Edupuganti
Publicat 2022Artigo -
18
Additional file 3 of EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arbovi... per Matthew H. Collins, Gail E. Potter, Matt D. T. Hitchings, Ellie Butler, Michelle Wiles, Jessie K. Kennedy, Sofia B. Pinto, Adla Betsaida Martins Teixeira, Arnau Casanovas‐Massana, Nadine Rouphael, Gregory A. Deye, Cameron P. Simmons, Luciano Andrade Moreira, Maurício Lacerda Nogueira, Derek A. T. Cummings, Albert I. Ko, Mauro Martins Teixeira, Srilatha Edupuganti
Publicat 2022Conjunto de Dados -
19
Additional file 4 of EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arbovi... per Matthew H. Collins, Gail E. Potter, Matt D. T. Hitchings, Ellie Butler, Michelle Wiles, Jessie K. Kennedy, Sofia B. Pinto, Adla Betsaida Martins Teixeira, Arnau Casanovas‐Massana, Nadine Rouphael, Gregory A. Deye, Cameron P. Simmons, Luciano Andrade Moreira, Maurício Lacerda Nogueira, Derek A. T. Cummings, Albert I. Ko, Mauro Martins Teixeira, Srilatha Edupuganti
Publicat 2022Conjunto de Dados -
20
Additional file 2 of EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arbovi... per Matthew H. Collins, Gail E. Potter, Matt D. T. Hitchings, Ellie Butler, Michelle Wiles, Jessie K. Kennedy, Sofia B. Pinto, Adla Betsaida Martins Teixeira, Arnau Casanovas‐Massana, Nadine Rouphael, Gregory A. Deye, Cameron P. Simmons, Luciano Andrade Moreira, Maurício Lacerda Nogueira, Derek A. T. Cummings, Albert I. Ko, Mauro Martins Teixeira, Srilatha Edupuganti
Publicat 2022Conjunto de Dados
Eines de cerca:
Matèries relacionades
Immunology
Virology
Medicine
Biology
Antibody
Virus
Internal medicine
Genetics
Immune system
Vaccination
Gene
Immunogenicity
Neutralizing antibody
Titer
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Pathology
Human immunodeficiency virus (HIV)
Clinical trial
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Immunity
Neutralization
Alternative medicine
Antibody titer
Biochemistry
CD8
Computer science
Placebo
Antigen